Breast Cancer Information, News and Updates

The addition of Genentech Inc’s cancer drug Avastin to chemotherapyslows the progress of breast cancer at two different doses,according to results of a large international trial released onSaturday.

More: continued here

This entry was posted on Monday, June 23rd, 2008 at 11:06 am and is filed under Breast Cancer News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.